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ABSTRACT
Objective. To explore anthropometric changes in normal-weight, overweight and
obese subjects who did not dropout or fail a weight loss program over the 16 treat-
ment weeks to improve patient motivation and treatment adherence.
Methods. A clinical intervention study was conducted among 271 (including 100
dropouts and/or failures) obese and overweight patients who consulted a nutrition
clinic in Barranquilla (Colombia) for the purpose of nutritional assessment. They
were subject to a personalized weekly follow-up consultation over the course of 16
weeks in which initial and the final Body Mass Index (BMI, kg/m2), photographs,
food consumption patterns, percentage weight loss, waist and hip circumference
were registered and grouped according to BMI, measuring treatment response. Data’s
nonparametric statistical comparison was made.
Results. In 62 patients from the BMI < 25 group, there is weight loss of 2.6% (3.1
SD), 5.5% (3.3 SD) in waist circumference and 3.0% (2.5 SD) in hip circumference.
In 67 patients from the 25 ≥ BMI < 30 group, there is weight loss of 3.8% (4.1 SD),
5.7% (4.5 SD) in waist circumference loss and 3.7% (3.0 SD) in hip circumference
loss. In 42 patients from the BMI > 30 group, there is weight loss of 4.8% (3.7 SD),
7.0% (3.6 SD) in waist circumference loss and 3.9% (2.4 SD) in hip circumference
loss. Monitoring is done every 4 weeks by the Friedman test, with significant differ-
ences between the three groups (p < 0.001). Patients do not drop out of treatment
because they start to see physical results in waist decrease. When comparing final val-
ues of initial waist/hip circumference ratios and waist/height ratios, a clear decrease
in the three BMI groups was observed (p < 0.001).
Conclusion. After three weeks of continuous treatment patients improved in all
overweight and obesity parameter indicators; there were not statistically significant
differences in hip circumference (HC) and waist loss (WC) (%) among the three BMI
groups (normal-weight, overweight, and obesity). In contrast, there were statistically
significant differences in weight loss (%) and waist-to-hip ratios. Based on anthropo-
metric outcomes and patient perception of their body image it can be concluded that
the waist circumference loss is the parameter that retains obese patients in the weight
loss program.
Subjects Nutrition
Keywords Treatment adherence, Overweight, Obesity, Waist circumference, Hip circumference,
Motivation
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INTRODUCTION
Overweight (body mass index, BMI 25–30 kg/m2) and obesity (BMI ≥ 30 kg/m2) are
preventable diseases defined as abnormal or excessive fat accumulation that sometimes
favours the onset of disease (WHO, 2013).
Over the years, the obesity prevalence significantly increases (Ogden et al., 2006) due to
a decrease in caloric expenditure and increased energy consumption, resulting from poor
diet and sedentary lifestyle (Centers for Disease Control and Prevention, 2013) coupled with
hormone physiopathology implications such as leptin (Sørensen, Echwald & Holm, 1996)
and ghrelin (Hinney et al., 2013).
There is a close relationship between waist circumference and cardiovascular risk
in obesity (Masia´ et al., 1998); concerned men and women commonly lose weight by
consuming less fat but not fewer calories rather than practicing the recommended
combination of hypocaloric diet associated with physical activity (Serdula et al., 1999;
Wadden, 1993) to achieve permanent changes in lifestyle (SIGN, 1996; NHS, 1997)
allowing better obesity control (Benı´tez Guerrero et al., 2009).
Some studies reference marital status (Cano Garcinun˜o et al., 2010), level of education
(Mazure et al., 2007) and social class (Da Veiga, Da Cunha & Sichieri, 2004) with
overweight and obesity, but it has been shown that these parameters are not considered
influential factors in the successful outcome of a treatment (Kuzmar, Corte´s & Rizo, in
press).
In some cases appetite suppressants that increase anorexigenic neurotransmitters in the
central nervous system (Yanovski & Yanovski, 2002) such as sibutramine (National Institute
for Clinical Excellence, 2001) and orlistat have been used, but the suppressants were only
continued if patients lost weight and maintained the weight loss without significant side
effects (Noe¨l & Pugh, 2002). Currently these drugs are suspended (Herna´ndez Garc´ıa, 2010)
and are under consumption alerts (Heitmann Ghigliotto, 2010).
Alternative overweight and obesity treatments are very popular but despite being widely
used, they have not been shown to be safe and effective (Allison et al., 2001).
In morbid obesity (BMI ≥ 40 kg/m2) sometimes lifestyle changes are not enough,
(National Institute for Clinical Excellence, 2002) necessitating bariatric surgery to achieve
effective weight loss (Morales et al., 2011).
In clinical practice it is important to predict nonabdominal, abdominal subcutaneous,
and visceral fat in patients by measuring BMI and waist circumference independently
(Janssen et al., 2002).
This study therefore seeks to determine which of the parameters monitored to improve
body image and overweight treatment: BMI decrease, weight percentage and waist and hip
circumference loss, could serve as patient motivation.
MATERIAL AND METHODS
Subjects
A clinical intervention study was conducted among 271 (233 women and 38 men)
overweight and obese participants who consulted a nutrition clinic in Barranquilla
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(Colombia) for the purpose of nutritional assessment. They were subject to a personalized
weekly follow-up consultation over the course of 16 weeks. The inclusion criteria were
voluntary assistance, patient desire to improve their aesthetic image, excluding those with
chronic diseases such as diabetes, kidney failure, etc., since patients came for aesthetic
reasons. This study does not consider patients who tried a diet to lose weight in the
previous month or earlier, as this aspect to analyse the resistance/adherence to current
treatment is not necessary. In turn, alcohol and tobacco consumption do not affect actual
results. 171 (63.1%) overweight or obese patients according to the WHO classification
(WHO, 2013) continued the study. The sample was composed of patients from 15 to
80 years of age collected over a period of 3 years.
The study was conducted according to Helsinki’s rules obtaining all patients informed
consent.
Methods
As in previous studies (Kokkinos et al., 1995), we assume changes in a nutritional treatment
can be seen in 16 continuous weeks. The study included a patient’s complete medical
record and a weekly WHO recommended medical-nutritional assessment (OMS, 1995) by
obtaining height, weight, waist and hip circumference data, as well as its own comparison
of their initial and final treatment body image through photographs for self-perception
control. We used an eating habits questionnaire similar to the Dana-Farber Cancer
Institute questionnaire (Dana-Farber Cancer Institute), asking about background and
habits at home and work that may relate to the patient’s health focusing on eating habits.
We made the weekly low calorie diets WHO-based (WHO) according to the questionnaire
response.
With the obtained data we calculate the initial and final BMI according to WHO (WHO,
2013; OMS, 1995) criteria, as well as weight, waist and hip loss percentages.
The data were analyzed using IBM SPSS Statistics version 22.0 software, checking the
normality and comparative nonparametric statistics on data that did not show a normal
distribution by Friedman’s test. A significance level of p < 0.05 is considered. This study
was approved by SEMI-Servicios Me´dicos Integrados of Barranquilla, Colombia.
RESULTS
The 63.1% of patients with successful loss in all the studied variables were analysed. 36.9%
of patients dropped out during the first three visits with no known medical reason or
significant relationships to sex and BMI; we assumed that patients discontinued the
treatment because they did not get the immediate results in waist loss they expected.
Changes begin to be perceived from the fourth week as shown in figures. Table 1 shows that
in 62 patients from the BMI < 25 group, there is weight loss of 2.6%(3.1 SD), 5.5%(3.3
SD) in waist circumference loss and 3.0%(2.5 SD) in the hip circumference loss. In 67
patients from the 25 ≤ BMI < 30 group, there is weight loss of 3.8%(4.1 SD), 5.7%(4.5
SD) in waist circumference loss and 3.7%(3.0 SD) in the hip circumference loss. 42 patients
from the BMI > 30 group, there is weight loss of 4.8%(3.7 SD), 7.0%(3.6 SD) in waist
circumference loss and 3.9%(2.4 SD) in the hip circumference loss. There were statistical
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Table 1 Results of initial and final BMI, weight, waist and hip circumference, and percentage loss in BMI groups at 16 treatment weeks (mean,
standard deviation and 95% confidence interval).
BMI (kg/m2) <25 25≥ BMI < 30 >30 p (Kruskal-Wallis)
n 62 67 42
i BMI mean (SD) 23.1 (1.3) 27.5 (1.5) 32.9 (3.5)
(CI 95%) (22.7–23.4) (27.2–27.9) (31.8–34.0)
<0.001
f BMI mean (SD) 22.5 (1.4) 26.5 (1.7) 31.3 (3.3)
(CI 95%) (22.1–22.8) (26.1–26.9) (30.3–32.3)
<0.001
Paired test (p) <0.001 <0.001 <0.001
i BMI - f BMI mean (SD) 0.6 (0.7) 1.0 (1.1) 1.6 (1.3)
(CI 95%) (0.4–0.8) (0.8–1.3) (1.2–2.0)
<0.001
Weight loss % mean (SD) 2.6 (3.1) 3.8 (4.1) 4.8 (3.7)
(CI 95%) (1.8–3.3) (2.8–4.8) (3.6–5.9)
<0.05
i waist mean (SD) 76.3 (5.6) 86.7 (7.3) 100.8 (11.4)
(CI 95%) (74.9–77.7) (85.0–88.5) (97.3–104.4)
<0.001
f waist mean (SD) 72.1 (5.4) 81.6 (6.5) 93.7 (10.0)
(CI 95%) (70.7–73.5) (80.0–83.2) (90.5–96.8)
<0.001
Paired test (p) <0.001 <0.001 <0.001
Waist loss % mean (SD) 5.5 (3.3) 5.7 (4.5) 7.0 (3.6)
(CI 95%) (4.6–6.3) (4.6–6.8) (5.9–8.1)
ns
i hip mean (SD) 96.4 (5.3) 105.8 (5.5) 115.3 (7.3)
(CI 95%) (95.0–97.7) (104.4–107.1) (113.0–117.6)
<0.001
f hip mean (SD) 93.5 (5.5) 101.9 (5.9) 110.8 (7.5)
(CI 95%) (92.1–94.9) (100.5–103.4) (108.5–113.1)
<0.001
Paired test (p) <0.001 <0.001 <0.001
Hip loss % mean (SD) 3.0 (2.5) 3.7 (3.0) 3.9 (2.4)
(CI 95%) (2.4–3.6) (2.9–4.4) (3.2–4.7)
ns
i waist/i hip ratio mean (SD) 0.79 (0.06) 0.82 (0.07) 0.88 (0.09)
(CI 95%) (0.78–0.81) (0.80–0.84) (0.85–0.90)
<0.001
f waist/f hip ratio mean (SD) 0.77 (0.06) 0.80 (0.06) 0.85 (0.07)
(CI 95%) (0.76–0.79) (0.79–0.82) (0.82–0.87)
<0.001
Paired test (p) <0.001 <0.001 <0.001
i waist/i height ratio mean (SD) 0.48 (0.04) 0.53 (0.04) 0.62 (0.06)
(CI 95%) (0.47–0.49) (0.52–0.54) (0.60–0.64)
<0.001
f waist/f height ratio mean (SD) 0.45 (0.03) 0.50 (0.03) 0.57 (0.06)
(CI 95%) (0.45–0.46) (0.49–0.51) (0.56–0.59)
<0.001
Paired test (p) <0.001 <0.001 <0.001
significant differences in waist, hip circumference (HC), waist circumference (WC),
waist/hip ratio and waist/height ratio shown in Table 1 paired test (p < 0.001). Friedman’s
test monitoring for weight (Fig. 1), waist (Fig. 2) and hip (Fig. 3) loss is done every 4 weeks,
with significant differences between the three groups (p < 0.001). Comparing final values
of initial waist/hip circumference ratios and waist/height ratios, a clear decrease in the
three BMI groups was observed (p < 0.001) (Table 1). When comparing self-perception
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Figure 1 Boxplot diagram. Weight loss percentage monthly variation in the three studied nutrition
groups. Friedman test p < 0.001.
Figure 2 Boxplot diagram. Waist loss percentage monthly variation in the three studied nutrition
groups. Friedman test p < 0.001.
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Figure 3 Boxplot diagram. Hip loss percentage monthly variation in the three studied nutrition groups.
Friedman test p < 0.001.
data through the initial and final week patient treatment photos, they clearly showed
satisfaction verifying their waist loss perception (Fig. 4).
DISCUSSION
The concept of body image changes during life affecting individual behaviour (Calado,
Lameiras & Rodr´ıguez, 2004), so it cannot be separated from the weight loss. In the present
study, we have obtained good results in a high percentage (63.1%) of patients who attended
the consultation to improve their body image and/or weight loss. These success rates are
highly variable in the literature (Hill & Williams, 1998; Paxton et al., 1999) and depends on
many factors (Paxton et al., 1991).
It is observed that even patients who attended the consultation to improve their body
image but were not overweight (WHO, 2013), lose BMI, weight, waist and hip, although it
is noted that weight stabilizes after 8 treatment weeks. The overweight (WHO, 2013) group
also stabilizes weight at 8 weeks; only the obese (WHO, 2013) group maintains an ongoing
weight loss until the end of treatment and may indicate the need to extend it for more
weeks.
In all cases, waist loss is superior to the other examined parameters. It continuously
decreases for 16 weeks with greater decreases in the obese (WHO, 2013) group and doesn’t
plateau in any of the three groups. Thus, it is a parameter for which many patients seek
superior tracking time, and is an appreciated body image index (Casper et al., 1979),
with very visual and comparable-to-initial-state results (Garner et al., 1980). Hip losses
are lower and temporarily appear similar to weight loss. Waist/hip ratio losses, after
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Figure 4 Treatment photograph. Patient’s photographs at week 1 and week 16 help motivate the patient,
demonstrating body image and self-perception changes. A: week number 1. B: week number 16.
16 treatment weeks, appear similar to waist loss in all BMI groups. Improved nutritional
status is evident in the three BMI groups; all indicative body image parameters (waist,
hip and waist/height ratio) significantly improved. We note that the waist/height ratio is
an important parameter of nutritional improvement status and its relationship to health.
Thus, this ratio is effective for predicting relative weight and simplifies the diagnosis of
overweight and obesity (Marroda´n et al., 2011).
CONCLUSION
After three weeks of continuous treatment, patients improved all overweight and obesity
parameters indicators; there were no statistically significant differences in hip circum-
ference (HC) and waist loss (WC) (%) among the three BMI groups (normal-weight,
overweight, and obesity). In contrast, there were statistically significant differences in
weight loss (%) and waist-to-hip ratios. Based on anthropometric outcomes and patient
perception of body image it can be concluded that the waist circumference loss is the
parameter that retain obese patients in the weight loss program.
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